GlobeNews Wire

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…

8 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 08, 2025 17:00 ET  | Source: TELA Bio, Inc. MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…

8 months ago

Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand

Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, Folqs First-Day Colostrum…

8 months ago

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced…

8 months ago

XORTX Completes USD $114,500 Private Placement

August 08, 2025 19:54 ET  | Source: XORTX Therapeutics Inc. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR…

8 months ago

Xauras Launches with Strong Global Momentum, Positioning Itself as a Game-Changer in the $100B DeFi Lending Market

London, UK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- August 2025 | Global – In a significant move that’s drawing attention…

8 months ago

AONMeetings Launches $3.99 Monthly Plan to Eliminate Hidden Webinar Fees

Des Moines, Iowa, Aug. 08, 2025 (GLOBE NEWSWIRE) -- AONMeetings today announced the release of a new pricing structure that…

8 months ago

Intermap Announces Date for Second Quarter Earnings

Company will announce second quarter 2025 financial results and host a conference call on August 14, 2025 August 08, 2025…

8 months ago

Longeveron Announces Up To $17.5 Million Public Offering

MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology…

8 months ago

REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an…

8 months ago